SCHEMBL4937846

SCHEMBL4937846

O=C(O)C=CC(=O)Nc1ccc(Nc2ccccc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.74
MAPT P10636 5/20 0.74
KDM4E B2RXH2 2/20 0.74
LPAR2 Q9HBW0 3/20 0.70
LPAR3 Q9UBY5 3/20 0.70
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
L3MBTL1 Q9Y468 2/20 0.68
LPAR1 Q92633 2/20 0.68
TDP2 O95551 1/20 0.68
GAA P10253 1/20 0.68
THRB P10828 1/20 0.68
NMT1 P30419 1/20 0.66
POLB P06746 2/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
LMNA P02545 1/20 0.60
NR4A1 P22736 1/20 0.60
CASP3 P42574 1/20 0.60
SENP7 Q9BQF6 1/20 0.60
HTT P42858 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7955720 1.00 ALDH1A1 (0.74) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL4937842 1.00 ALDH1A1 (0.74) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL20998498 1.00 ALDH1A1 (0.74) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL11502177 0.94 CASP3 (0.67) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL2831352 0.92 ALDH1A1 (0.79) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL1169889 0.92 ALDH1A1 (0.79) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL1683255 0.92 ALDH1A1 (0.79) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL9360711 0.90 ALDH1A1 (0.76) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL29262225 0.90 ALDH1A1 (0.76) ALDH1A1MAPTKDM4ELPAR2LPAR3
SCHEMBL15667293 0.90 ALDH1A1 (0.76) ALDH1A1MAPTKDM4ELPAR2LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342126-B2 Process for the preparation of 4-oxo-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid CROMPTON CORPORATION (US) 2008-03-11 US claimed
WO-2006049676-A1 PROCESS FOR THE PREPARATION OF 4-OXO-4-((4-(PHENYLAMINO) AMINO)-2-BUTENOIC ACID CHEMTURA CORPORATION (US) 2006-05-11 WO claimed
US-20060089511-A1 Process for the preparation of 4-OXO-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid CROMPTON CORPORATION 2006-04-27 US claimed
US-5936038-A MIXTURE CONTAINING ELASTOMER HAVING PENDANT REACTIVE AMINE GROUP AND PHENOLIC RESIN CURATIVE THE UNIVERSITY OF AKRON (US) 1999-08-10 US claimed
CN-117916283-A Curable conductive composition 贺利氏电子化学材料有限公司 2024-04-19 CN disclosed
US-7342126-B2 Process for the preparation of 4-oxo-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid CROMPTON CORPORATION (US) 2008-03-11 US disclosed
US-7342126-B2 Process for the preparation of 4-oxo-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid CROMPTON CORPORATION (US) 2008-03-11 US disclosed
US-7342126-B2 Process for the preparation of 4-oxo-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid CROMPTON CORPORATION (US) 2008-03-11 US disclosed
WO-2006049676-A1 PROCESS FOR THE PREPARATION OF 4-OXO-4-((4-(PHENYLAMINO) AMINO)-2-BUTENOIC ACID CHEMTURA CORPORATION (US) 2006-05-11 WO disclosed
WO-2006049676-A1 PROCESS FOR THE PREPARATION OF 4-OXO-4-((4-(PHENYLAMINO) AMINO)-2-BUTENOIC ACID CHEMTURA CORPORATION (US) 2006-05-11 WO disclosed
US-20060089511-A1 Process for the preparation of 4-OXO-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid CROMPTON CORPORATION 2006-04-27 US disclosed
US-20060089511-A1 Process for the preparation of 4-OXO-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid CROMPTON CORPORATION 2006-04-27 US disclosed
EP-0029598-A1 An improved high solids coating composition of a low molecular weight acrylic polymer and a polyisocyanate cross-linking agent, and a substrate coated therewith E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-03 EP disclosed
EP-0029595-A1 An improved high solids coating composition of a low molecular weight glycidyl acrylic polymer and an alkylated melamine cross-linking agent, and a substrate coated therewith E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-03 EP disclosed
EP-0029596-A1 An improved high solids coating composition of a low molecular weight acrylic polymer and a nitrogen resin cross-linking agent, and a substrate coated therewith E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-03 EP disclosed
EP-0029594-A1 A liquid acrylic coating composition, articles coated therewith and process for preparing said coated articles E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-03 EP disclosed
EP-0029597-A1 An aqueous thermosetting acrylic coating composition, articles coated therewith, and process for preparing said coated articles E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-03 EP disclosed
EP-0029593-A1 A coating composition based on acrylic polymer blends, articles coated therewith, and process for preparing said coated articles E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-06-03 EP disclosed
WO-1981000233-A1 CLEAR COAT/COLOR COAT FINISH CONTAINING AN ULTRAVIOLET LIGHT STABILIZER DU PONT 1981-02-05 WO disclosed
US-4010140-A Age resistant resin compositions and admixtures useful as adhesives THE GOODYEAR TIRE & RUBBER COMPANY (US) 1977-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089511-A1 Process for the preparation of 4-OXO-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid ALOX5, ALAD, ALOX15 ALDH1A1 1139/4885MAPT 2401/4885KDM4E 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.